Nalaganje...
Personalized medicine with biologics for severe type 2 asthma: current status and future prospects
Asthma affects more than 300 million people worldwide and poses a large socioeconomic burden, particularly in the 5% to 10% of severe asthmatics. So far, each entry of new biologics in clinical trials has led to high expectations for treating all severe asthma forms, but the outcome has only been su...
Shranjeno v:
| izdano v: | MAbs |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5800381/ https://ncbi.nlm.nih.gov/pubmed/29035619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2017.1392425 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|